MUMBAI: Reliance Industries, through its biotechnology subsidiary Reliance Life Sciences or RLS, has launched its diagnostics operations and is currently conducting over 2,000 covid-19 tests every day. "From zero per day, it is currently doing over 2,000 tests every day," RIL said in its financial presentation to analysts after its fourth-quarter results on 30 April.
RLS has developed its own confirmatory tests for covid-19, which are available to all RIL employees on priority and will soon be rolled out in the community.
Mint had in December 2019 reported that RLS is trying to build a network of pathology labs and is scouting for partners. To begin with, it plans to set up 20-30 labs.